Harvard Women's Health Watch

New drug shows promise for early Alzheimer's disease

A new drug, aducanumab, slowed cognitive decline in people with early Alzheimer's in a small study. A larger study is planned.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »